Drugmakers Et Al Accused Of Anti-FDA Campaigning

11 August 1996

Drug, medical device, biotechnology and tobacco companies gave at least $3.5 million for "deceptive" anti-Food and Drug Administration campaigns, according to a new report from Public Citizen. The money was given to conservative think-tanks that have mounted what Public Citizen called a "vitriolic anti-FDA public relations campaign."

These industry-funded think-tanks generated and circulated a series of myths being used to justify pending legislation that would weaken the agency's ability to protect the public from unsafe and ineffective drugs, medical devices, blood products and food additives, it was noted. This "misleading case" has been manufactured by industries that stand to make huge additional profits, according to Joan Claybrook, president of Public Citizen.

A Million for Your Thoughts; The Industry-Funded Campaign by Conservative Think-Tanks documents the contribution made by these companies to eight conservative think-tanks since 1992. Because limited disclosure requirements allow corporations to hide most of their gifts, actual funding is assumed to be much higher, according to the group.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight